ArticleJournal of cancer research and clinical oncology2013

KRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines.

Isabelle Messner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.